Literature DB >> 26135017

Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer.

Alexander M Th Schmitz1, Wouter B Veldhuis, Marian B E Menke-Pluijmers, Wybe J M van der Kemp, Tijl A van der Velden, Marc C J M Kock, Pieter J Westenend, Dennis W J Klomp, Kenneth G A Gilhuijs.   

Abstract

OBJECTIVES: To describe and to correlate tumor characteristics on multiparametric 7 tesla (T) breast magnetic resonance imaging (MRI) with prognostic characteristics from postoperative histopathology in patients with breast cancer.
MATERIALS AND METHODS: Institutional review board approval and written informed consent of 15 women (46-70 years) with 17 malignant lesions were obtained. In this prospective study (March 2013 to March 2014), women were preoperatively scanned using dynamic contrast-enhanced MRI, diffusion-weighted imaging, and 31-phosphorus spectroscopy (¹³P-MRS). The value of the protocol was assessed to quantify tumor differentiation and proliferation. Dynamic contrast-enhanced MRI was assessed according to the American College of Radiology Breast Imaging Reporting and Data System-MRI lexicon. Apparent diffusion coefficients (ADCs) were calculated from diffusion-weighted imaging. On ¹³P-MRS, at the location of the tumor, the amount of phosphorus components was obtained in a localized spectrum. In this spectrum, the height of phosphodiester (PDE) and phosphomonoester (PME) peaks was assessed to serve as a measure for metabolic activity, stratifying tumors into a PDE > PME, PDE = PME, or PDE < PME group. Tumor grade and mitotic count from resection specimen were compared with the MRI characteristics using explorative analyses.
RESULTS: On dynamic contrast-enhanced MRI, the mean tumor size was 24 mm (range, 6-55 mm). An inverse trend was seen between ADC and tumor grade (P = 0.083), with mean ADC of 867 × 10⁻⁶ mm²/s for grade 1 (N = 4), 751 × 10⁻⁶ mm²/s for grade 2 (N = 6), and 659 × 10⁻⁶ mm²/s for grade 3 (N = 2) tumors. Between P-MR spectra and mitotic count, a relative increase of PME over PDE showed significant association with increasing mitotic counts (P = 0.02); a mean mitotic count of 6 was found in the PDE greater than PME group (N = 7), 8 in the PDE = PME group (N = 1), and 17 in the PDE < PME group (N = 3).
CONCLUSIONS: Multiparametric 7 T breast MRI is feasible in clinical setting and shows association between ADC and tumor grade, and between ¹³P-MRS and mitotic count.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26135017     DOI: 10.1097/RLI.0000000000000183

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  15 in total

Review 1.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

Review 2.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

Review 3.  The potential of multiparametric MRI of the breast.

Authors:  Katja Pinker; Thomas H Helbich; Elizabeth A Morris
Journal:  Br J Radiol       Date:  2016-11-02       Impact factor: 3.039

4.  Direct Regularization From Co-Registered Contrast MRI Improves Image Quality of MRI-Guided Near-Infrared Spectral Tomography of Breast Lesions.

Authors:  Limin Zhang; Shudong Jiang; Yan Zhao; Jinchao Feng; Brian W Pogue; Keith D Paulsen
Journal:  IEEE Trans Med Imaging       Date:  2018-05       Impact factor: 10.048

Review 5.  Diffusion-weighted breast MRI: Clinical applications and emerging techniques.

Authors:  Savannah C Partridge; Noam Nissan; Habib Rahbar; Averi E Kitsch; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2016-09-30       Impact factor: 4.813

Review 6.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

Review 7.  [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].

Authors:  K Pinker; M A Marino; A Dr Meyer-Baese; T H Helbich
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

8.  Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.

Authors:  A M T Schmitz; W B Veldhuis; M B E Menke-Pluijmers; W J M van der Kemp; T A van der Velden; M A Viergever; W P T M Mali; M C J M Kock; P J Westenend; D W J Klomp; K G A Gilhuijs
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

Review 9.  Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.

Authors:  Naranamangalam R Jagannathan; Uma Sharma
Journal:  Metabolites       Date:  2017-06-07

Review 10.  DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.

Authors:  Jessica M Winfield; Geoffrey S Payne; Alex Weller; Nandita M deSouza
Journal:  Top Magn Reson Imaging       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.